ChaMP-CMD: A Phenotype-Blinded, Randomized Controlled, Cross-Over Trial

医学 心绞痛 氨氯地平 随机对照试验 雷诺嗪 内科学 心脏病学 运动测验 加拿大心血管学会 冠状动脉疾病 心率 血压 心肌梗塞
作者
Aish Sinha,Haseeb Rahman,Abdel Douiri,Ozan M. Demir,Kalpa De Silva,Brian Clapp,Ian Webb,Ankur Gulati,Pedro Pinho,Utkarsh Dutta,Howard Ellis,Ajay M. Shah,Amedeo Chiribiri,Michael Marber,David J. Webb,Divaka Perera
出处
期刊:Circulation [Lippincott Williams & Wilkins]
卷期号:149 (1): 36-47 被引量:8
标识
DOI:10.1161/circulationaha.123.066680
摘要

BACKGROUND: Angina with nonobstructive coronary arteries is a common condition for which no effective treatment has been established. We hypothesized that the measurement of coronary flow reserve (CFR) allows identification of patients with angina with nonobstructive coronary arteries who would benefit from anti-ischemic therapy. METHODS: Patients with angina with nonobstructive coronary arteries underwent blinded invasive CFR measurement and were randomly assigned to receive 4 weeks of amlodipine or ranolazine. After a 1-week washout, they crossed over to the other drug for 4 weeks; final assessment was after the cessation of study medication for another 4 weeks. The primary outcome was change in treadmill exercise time, and the secondary outcome was change in Seattle Angina Questionnaire summary score in response to anti-ischemic therapy. Analysis was on a per protocol basis according to the following classification: coronary microvascular disease (CMD group) if CFR<2.5 and reference group if CFR≥2.5. The study protocol was registered before the first patient was enrolled (International Standard Randomised Controlled Trial Number: ISRCTN94728379). RESULTS: Eighty-seven patients (61±8 years of age; 62% women) underwent random assignment (57 CMD group and 30 reference group). Baseline exercise time and Seattle Angina Questionnaire summary scores were similar between groups. The CMD group had a greater increment (delta) in exercise time than the reference group in response to both amlodipine (difference in delta, 82 s [95% CI, 37–126 s]; P <0.001) and ranolazine (difference in delta, 68 s [95% CI, 21–115 s]; P =0.005). The CMD group reported a greater increment (delta) in Seattle Angina Questionnaire summary score than the reference group in response to ranolazine (difference in delta, 7 points [95% CI, 0–15]; P =0.048), but not to amlodipine (difference in delta, 2 points [95% CI, –5 to 8]; P =0.549). CONCLUSIONS: Among phenotypically similar patients with angina with nonobstructive coronary arteries, only those with an impaired CFR derive benefit from anti-ischemic therapy. These findings support measurement of CFR to diagnose and guide management of this otherwise heterogeneous patient group.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
咖啡博士完成签到,获得积分10
1秒前
韭黄发布了新的文献求助10
2秒前
Singularity完成签到,获得积分0
4秒前
JamesPei应助zq采纳,获得10
5秒前
所所应助韭黄采纳,获得10
9秒前
江霭完成签到,获得积分10
12秒前
鲤鱼青槐完成签到,获得积分10
21秒前
量子星尘发布了新的文献求助10
22秒前
25秒前
缥缈的冰旋完成签到,获得积分10
25秒前
31秒前
32秒前
ailemonmint完成签到 ,获得积分10
32秒前
33秒前
玉ER完成签到,获得积分10
34秒前
35秒前
四十四次日落完成签到 ,获得积分10
35秒前
科研通AI2S应助羊二呆采纳,获得10
35秒前
英吉利25发布了新的文献求助10
37秒前
38秒前
水晶茶杯发布了新的文献求助10
39秒前
欢欢完成签到,获得积分10
40秒前
茯苓完成签到 ,获得积分10
42秒前
小鱼发布了新的文献求助10
43秒前
香香丿完成签到 ,获得积分10
43秒前
44秒前
万能图书馆应助zz123采纳,获得10
44秒前
杜康完成签到,获得积分10
44秒前
Cheung2121发布了新的文献求助10
44秒前
医学小王完成签到 ,获得积分10
45秒前
47秒前
刘涵完成签到 ,获得积分10
48秒前
帅气的沧海完成签到 ,获得积分10
49秒前
辣辣辣辣辣辣完成签到 ,获得积分10
52秒前
53秒前
56秒前
乐观半兰完成签到,获得积分10
58秒前
58秒前
小丸子和zz完成签到 ,获得积分10
59秒前
量子星尘发布了新的文献求助10
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038112
求助须知:如何正确求助?哪些是违规求助? 3575788
关于积分的说明 11373801
捐赠科研通 3305604
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022